cetpinhibition.org

GeneticsLandmark

The human CETP gene is cloned and sequenced for the first time (Nature 1987)

Original title: Cloning and sequencing of human cholesteryl ester transfer protein cDNA

Nature · · 10

Drayna D, Jarnagin AS, McLean J, Henzel W, Kohr W, Fielding C, Lawn R

Reverse cholesterol transport returns excess peripheral cholesterol to the liver through cellular efflux, esterification by LCAT on HDL, transfer of the resulting cholesteryl esters to LDL and VLDL by CETP, and hepatic receptor-mediated removal, but the CETP step was the least well characterized of these, with prior purified preparations differing considerably in reported molecular mass, abundance, and specificity. Building on a recently described highly active human plasma CETP preparation of Mr 74,000 purified about 100,000-fold, the authors used a partial amino acid sequence from this purified protein to clone and sequence complementary DNA for CETP derived from human liver DNA, then used the cloned DNA to detect CETP messenger RNA across a number of human tissues.

Read the paper (DOI)PubMed

Original abstract

The transfer of insoluble cholesteryl esters among lipoprotein particles is a vital step in normal cholesterol homeostasis and may be involved in the development of atherosclerosis. Extrahepatic tissues lack the enzymes required for the degradation of sterols to the excretable form of bile acids. Cholesterol synthesized in these tissues in excess of that needed for the synthesis of cell membranes or steroid hormones must accordingly be returned through the plasma to the liver for catabolism. The series of reactions involved has been termed reverse cholesterol transport. Catalysed steps of this pathway are believed to include an efflux from peripheral cells, which generates a diffusion gradient between these membranes and extracellular fluid; esterification of this cholesterol by lecithin-cholesterol acyltransferase (LCAT) (phosphatidylcholine-sterol acyltransferase) acting on species of high-density lipoproteins; transfer of the cholesteryl esters formed (largely to low- and very low-density lipoproteins) (LDL and VLDL) by a cholesteryl ester transfer protein (CETP); and removal of these lipoproteins, together with their cholesteryl ester content, by the liver through receptor-mediated and nonspecific endocytosis. Of these steps, the CETP reaction is the least characterized. Several laboratories have reported the purification from human plasma of proteins active on cholesteryl ester transfer between lipoprotein particles and possibly between cells and plasma. However, the reported relative molecular mass (Mr), abundance and specificity of the purified activities have differed considerably. We have recently described the preparation of a highly active CETP of Mr 74,000 purified about 100,000-fold from human plasma, which may represent the functional component of earlier preparations. Using a partial amino-acid sequence from this purified protein, CETP complementary DNA derived from human liver DNA has been cloned and sequenced and the cloned DNA used to detect CETP messenger RNA in a number of human tissues.

geneticsmechanisms

Summary written by cetpinhibition.org from the published abstract; figures as published. Page updated 19 August 2026. Methods.